# Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

> **NCT04476901** · PHASE2 · RECRUITING · sponsor: **Joshua M Hare** · enrollment: 136 (estimated)

## Conditions studied

- Non-ischemic Dilated Cardiomyopathy

## Interventions

- **BIOLOGICAL:** allogeneic human mesenchymal stem cells (hMSCs)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04476901
- **Lead sponsor:** Joshua M Hare
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-05-07
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2026-03-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04476901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04476901, "Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04476901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*